Answers are grounded in this paper and cite their sources.
The HemoCue 201(+) showed greater discriminating power for detecting anemia in prospective blood donors than the micro-Hct method. Both presented equivalent deferral error rates of nonanemic potential donors. Compared to the micro-Hct, HemoCue 201(+) reduces the risk of anemic female donors giving blood, specially for those with lower Hb levels, without increasing the deferral of nonanemic potential donors.
No takes yet. Share an insight, caveat, or question.
Mendrone et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: